State Street’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-35,555
| Closed | -$81.8K | – | 4682 |
|
|
2023
Q1 | $81.8K | Hold |
35,555
| – | – | ﹤0.01% | 4382 |
|
|
2022
Q4 | $62.2K | Hold |
35,555
| – | – | ﹤0.01% | 4505 |
|
|
2022
Q3 | $92K | Hold |
35,555
| – | – | ﹤0.01% | 4488 |
|
|
2022
Q2 | $102K | Hold |
35,555
| – | – | ﹤0.01% | 4526 |
|
|
2022
Q1 | $288K | Buy |
35,555
+2,341
| +7% | +$19K | ﹤0.01% | 4255 |
|
|
2021
Q4 | $266K | Hold |
33,214
| – | – | ﹤0.01% | 4225 |
|
|
2021
Q3 | $395K | Buy |
33,214
+13,730
| +70% | +$163K | ﹤0.01% | 4069 |
|
|
2021
Q2 | $302K | Sell |
19,484
-84,490
| -81% | -$1.31M | ﹤0.01% | 4047 |
|
|
2021
Q1 | $2.5M | Sell |
103,974
-3,428
| -3% | -$82.3K | ﹤0.01% | 3347 |
|
|
2020
Q4 | $3.17M | Buy |
107,402
+5,641
| +6% | +$166K | ﹤0.01% | 3171 |
|
|
2020
Q3 | $1.56M | Buy |
101,761
+6,238
| +7% | +$95.4K | ﹤0.01% | 3293 |
|
|
2020
Q2 | $2.39M | Buy |
95,523
+4,727
| +5% | +$118K | ﹤0.01% | 3110 |
|
|
2020
Q1 | $1.85M | Sell |
90,796
-4,337
| -5% | -$88.5K | ﹤0.01% | 3095 |
|
|
2019
Q4 | $2.94M | Buy |
95,133
+7,619
| +9% | +$235K | ﹤0.01% | 3099 |
|
|
2019
Q3 | $2.92M | Buy |
87,514
+436
| +0.5% | +$14.6K | ﹤0.01% | 3069 |
|
|
2019
Q2 | $2.79M | Buy |
87,078
+7,560
| +10% | +$242K | ﹤0.01% | 3103 |
|
|
2019
Q1 | $2.28M | Buy |
79,518
+2,887
| +4% | +$82.9K | ﹤0.01% | 3107 |
|
|
2018
Q4 | $3.08M | Sell |
76,631
-1,686
| -2% | -$67.8K | ﹤0.01% | 2936 |
|
|
2018
Q3 | $3.66M | Buy |
78,317
+19,001
| +32% | +$887K | ﹤0.01% | 3013 |
|
|
2018
Q2 | $4.88M | Buy |
59,316
+56,953
| +2,410% | +$4.69M | ﹤0.01% | 2864 |
|
|
2018
Q1 | $99K | Buy |
+2,363
| New | +$99K | ﹤0.01% | 3615 |
|